Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 1.32T, Eli Lilly(LLY) trades at $1,406.97. The stock has a price-to-earnings ratio of 46.36 and currently yields dividends of 0.47%.
During the trading session on 2026-11-03, Eli Lilly(LLY) shares reached a daily high of $1,437.00 and a low of $1,389.00. At a current price of $1,406.97, the stock is +1.3% higher than the low and still -2.1% under the high.
Trading volume for Eli Lilly(LLY) stock has reached 1.66M, versus its average volume of 2.92M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,449.68 and a low of $850.51.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,449.68 and a low of $850.51.
LLY News
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company is studying LY3867070 in healthy partici...
Eli Lilly's weight-loss drugs get all the headlines, but CEO David Ricks is betting the company's next act looks nothing like its last one. Here is what it woul...
Over the past two years, Eli Lilly (LLY -0.42%) has hardly performed like a mature pharmaceutical company. The company's financial results have looked much more...
Analyst ratings
85%
of 33 ratingsMore LLY News
Sales and profits from GLP-1 weight-loss and diabetes drugs like Ozempic and Wegovy are already huge. They're only going to get bigger. Eli Lilly's (LLY +3.19%)...
Mounjaro and Zepbound just handed Lilly a blowout quarter, but falling realized drug prices and one-time revenue boosts that won't repeat raise real questions a...
Eli Lilly (NYSE:LLY) licensed SpeechDx’s Alzheimer’s speech biomarker dataset to expand its work on AI driven digital diagnostics. The SpeechDx library adds la...
Eli Lilly (LLY) just cleared a high bar. Third quarter sales and profit topped analyst forecasts, powered by strong demand for Mounjaro and Zepbound, and manage...
Eli Lilly (LLY +3.19%), as a pharma giant, offers investors a certain sense of safety in any market environment. This is because, at all times, patients need th...
So you're thinking of investing in Eli Lilly (LLY +3.19%) stock and you're wondering how it will perform by 2030 -- about four years from now. No one can know e...
On Friday, Elon Musk said Eli Lilly (NYSE:LLY) has "some banger drugs coming out”, after the drugmaker’s CEO Dave Ricks took on a “bet” responding to venture in...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.